Article
Temps de lecture : 6 min
9 septembre 2026
SANTÉ COMMUNAUTAIRE ET MONDIALE
{{cartTotalQuantity}}
Gamme de diagnostic moléculaire
Instruments et logiciel
Solutions Cepheid
Tester partout dans le monde
Diagnostics oncologiques
Bonne gestion des antibiotiques
Cepheid’s Insights
Webinaires
Cepheid RADAR
Support Center
Nous contacter
À propos de Cepheid
Mission et histoire
Événements
Distributeurs
Opportunités de développement commercial
Innover avec Cepheid
Venez découvrir la moto Cepheid
Actualités
Notre leadership
WHO EUL
Xpert® Hemorrhagic Fever Panel
When Clarity Matters Most.
Rapid Answers. Confident Action. No Compromise.
WHO EUL only. Peut ne pas être disponible dans tous les pays.
Le besoin
La solution
L’impact
Rapidly identify patients with suspected viral hemorrhagic fever
Support timely infection control and outbreak response
1. CDC. Screening and Evaluating an Ill Person for Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/diagnosis-testing/index.html
2. CDC. Infection Prevention and Control for Patients with Suspected or Confirmed Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html [ecdc.europa.eu]
3. WHO. Lassa Fever Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/lassa-fever [ijprems.com]
4. CDC. Lassa Fever Fact Sheet. https://stacks.cdc.gov/view/cdc/12236/cdc_12236_DS1.pdf [cdc.gov]
5. World Health Organization. Marburg virus disease - Equatorial Guinea and the United Republic of Tanzania. Disease Outbreak News, 8 mai 2023. [who.int]
6. Centers for Disease Control and Prevention (CDC). History of Marburg Outbreaks. Updated 2025. [cdc.gov]
7. World Health Organization. Crimean-Congo hemorrhagic fever: Fact Sheet. Updated 20 février 2025. [who.int]
8. UK Health Security Agency. Crimean-Congo hemorrhagic fever: origins, reservoirs, transmission and guidelines. Updated 2025. [gov.uk]
Xpert Hemorrhagic Fever Panel:
9. FDA 510(k) Decision Summary, Xpert® Hemorrhagic Fever Panel (K253653). Inactivation study results demonstrating viral inactivation during sample preparation are described in the submission documentation (see p. 23). Joignable au : https://www.accessdata.fda.gov/cdrh_docs/reviews/K253653.pdf.
1. CDC. Screening and Evaluating an Ill Person for Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/diagnosis-testing/index.html
2. CDC. Infection Prevention and Control for Patients with Suspected or Confirmed Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html [ecdc.europa.eu]
Fiche Technique
ENG
MSDS/FDS
ENG
MSDS/FDS
FRANÇAIS
Notice d’utilisation
ENG
Cartridge Preparation
ENG
Article
Temps de lecture : 6 min
9 septembre 2026
SANTÉ COMMUNAUTAIRE ET MONDIALE
Article
Temps de lecture : 5 min
12 juin 2026
SANTÉ COMMUNAUTAIRE ET MONDIALE